| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/11/1998 | EP0823478A2 Human cartilage gp 39-like gene |
| 02/11/1998 | EP0822993A1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1 |
| 02/11/1998 | EP0822987A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 02/11/1998 | EP0822986A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds |
| 02/11/1998 | EP0822984A1 Human tumor necrosis factor receptors |
| 02/11/1998 | EP0822983A1 Apopain |
| 02/11/1998 | EP0822941A1 Monoclonal antibodies against hiv-1 and vaccines made thereof |
| 02/11/1998 | EP0822834A1 Recombinant (beta)-cell and uses thereof |
| 02/11/1998 | EP0822829A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 02/11/1998 | CN1173184A Identitication, purification and uses of leczymes and carbohydrate ligands |
| 02/11/1998 | CN1173128A Polynucleotide compositions |
| 02/10/1998 | US5717058 Viricides, treatment of genetic disorders |
| 02/10/1998 | US5716832 Growing packaging cells having viral protein-coding sequences which produce target cell-specific retroviruses; gene therapy, antitumor agents |
| 02/10/1998 | US5716826 Recombinant retroviruses |
| 02/10/1998 | US5716821 Pure, recombinant virus particles comprising respiratory syncytial virus rna dependent rna polymerase, a phosphoprotein, a nucleocapsid, a structural protein, rna sequences; vaccines |
| 02/10/1998 | US5716806 Genetic engineering; medical diagnosis |
| 02/10/1998 | US5716789 Incubating cells; measuring activation |
| 02/10/1998 | US5716788 Biochemical immobilization; genetic engineered treatment of methotrexate resistant cancer |
| 02/10/1998 | US5716622 Functionally active regions of signal transducer and activators of transcription |
| 02/10/1998 | US5716616 Sampling bone marrow; adminstering by intravenous infusion |
| 02/10/1998 | US5716613 Genetic engineering |
| 02/10/1998 | US5715835 Methods for treating and reducing the potential for cardiovascular disease using methioninase compositions |
| 02/10/1998 | US5715824 Biological apparatus comprising a vessel for foaming procedure |
| 02/05/1998 | WO1998004728A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | WO1998004726A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 02/05/1998 | WO1998004720A1 Method and reagents for genetic immunization |
| 02/05/1998 | WO1998004718A1 Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses |
| 02/05/1998 | WO1998004714A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 02/05/1998 | WO1998004709A2 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | WO1998004705A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 02/05/1998 | WO1998004702A2 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | WO1998004698A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
| 02/05/1998 | WO1998004694A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004693A2 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1998004691A1 Human proteolipid |
| 02/05/1998 | WO1998004689A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 02/05/1998 | WO1998004590A1 Conservin compositions and therapeutic and diagnostic uses therefor |
| 02/05/1998 | WO1998004585A2 Novel human macrophage antigen |
| 02/05/1998 | WO1998004291A1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 02/05/1998 | WO1998004287A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | WO1998004286A2 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | WO1998004242A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | WO1997040183A3 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 02/05/1998 | WO1997040173A3 Pi 3-kinase fusion mutants and uses thereof |
| 02/05/1998 | WO1997040151A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997040069A3 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | WO1997032991A3 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors |
| 02/05/1998 | DE19631357A1 Vektor zur Aktivierung des Immunsystems gegen mit Papillomviren bzw. Sequenzen davon assoziierten Zellen Vector for activation of the immune system with papillomavirus or sequences thereof associated cells |
| 02/05/1998 | DE19631189A1 Neuartige kationische Amphiphile für den liposomalen Gentransfer Novel cationic amphiphiles for the liposomal gene transfer |
| 02/05/1998 | DE19630896A1 Verwendung eines Gens für humanen vaskulären Endothelzell-Wachstumsfaktor zur direkten Gentherapie Use of a gene for human vascular endothelial growth factor gene therapy for direct |
| 02/05/1998 | CA2744096A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| 02/05/1998 | CA2289699A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2262533A1 2-methoxyestradiol and p53-induced apoptosis in cancer cells |
| 02/05/1998 | CA2262013A1 Herpes simplex virus icp4 is an inhibitor of apoptosis |
| 02/05/1998 | CA2262006A1 Method and reagents for genetic immunization |
| 02/05/1998 | CA2261990A1 Recombinant pox virus for immunization against tumor-associated antigens |
| 02/05/1998 | CA2261718A1 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 02/05/1998 | CA2261581A1 Secreted proteins and polynucleotides encoding them |
| 02/05/1998 | CA2261575A1 Novel human macrophage antigen |
| 02/05/1998 | CA2261567A1 The use of proteinase inhibitors for prevention or reduction of bone resorption |
| 02/05/1998 | CA2261563A1 Human proteolipid |
| 02/05/1998 | CA2261071A1 Assembly-deficient herpesvirus vaccine |
| 02/05/1998 | CA2260740A1 A novel human mrna editing enzyme |
| 02/05/1998 | CA2259948A1 Use of a lestr/fusin/cxcr4 receptor ligand chemokine (sdf-1) for treating or preventing hiv-type viral infection |
| 02/05/1998 | CA2259924A1 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 02/05/1998 | CA2259129A1 Pro-protein converting enzyme |
| 02/04/1998 | EP0821741A1 Glucose-inducible recombinant viral vector |
| 02/04/1998 | EP0821740A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
| 02/04/1998 | EP0821739A1 An adenovirus helper-virus system |
| 02/04/1998 | EP0821733A2 Genetic markers for breast and ovarian cancer |
| 02/04/1998 | EP0821698A1 Protective helicobacter antigens |
| 02/04/1998 | EP0821591A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same |
| 02/04/1998 | EP0821583A1 Dna vaccines against rotavirus infections |
| 02/04/1998 | EP0652967B1 Self-assembling replication defective hybrid virus particles |
| 02/04/1998 | EP0568537B1 Genetic modification of endothelial cells |
| 02/04/1998 | CN1172502A In vivo mutations and polymorphisms in 17 q -linked breast and ovarian cancer susceptibility gene |
| 02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
| 02/04/1998 | CN1172164A Promoting human lung glandular cancer cell differentiation CDNa and its eucaryon express carrier and application |
| 02/04/1998 | CN1172163A Promoting human lung glandular cancer cell differentiation CDNA and its eucaryon express carrier and application |
| 02/04/1998 | CN1172162A Promoting human lung glandular cancer cell differentiation CDNA and its eucaryon expressing carrier and application |
| 02/03/1998 | US5714588 Enhancement of cellular attachment using H3 protein |
| 02/03/1998 | US5714383 Method and reagent for treating chronic myelogenous leukemia |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | CA1339654C Gene therapy using gene fusion for genetic or acquired disorders |
| 01/29/1998 | WO1998003669A2 Vectors for inhibiting hiv and tumor growth |
| 01/29/1998 | WO1998003660A1 Feline polynucleotide vaccine formula |
| 01/29/1998 | WO1998003659A1 Avian polynucleotide vaccine formula |
| 01/29/1998 | WO1998003658A1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 01/29/1998 | WO1998003653A2 Method for preparing transgenic non-human mammalian organs for transplantation to humans, and nucleotide sequences therefor |
| 01/29/1998 | WO1998003648A1 Fas ligand-like protein, its production and use |
| 01/29/1998 | WO1998003542A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003196A1 Intradermal bovine polynucleotide vaccine |
| 01/29/1998 | WO1998003195A1 Methods and compositions for modulation of growth response |
| 01/29/1998 | WO1998003159A2 Lipid-binding proteins and their therapeutic and diagnostic use |
| 01/29/1998 | WO1997047732A3 Hexameric fusion proteins and uses therefor |
| 01/29/1998 | WO1997046253A3 Immunotherapy for autoimmune disease |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |